Literature DB >> 9558193

Arterial obliteration in POEMS syndrome: possible role of vascular endothelial growth factor.

M Soubrier1, R Guillon, J J Dubost, A F Serre, J M Ristori, L Boyer, B Sauvezie.   

Abstract

Acute arterial obliteration is a newly acknowledged manifestation of the POEMS syndrome (plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes), in which overproduction of proinflammatory cytokines has been implicated. We describe a case in which serum levels of proinflammatory cytokines were normal or slightly raised. In contrast, vascular endothelial growth factor (VEGF) was greatly increased. This angiogenic and vascular permeability factor is involved in the development of atheromatous and thrombotic lesions and may be responsible for the arterial complications of the disorder.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9558193

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

1.  Ischemic stroke in patients with POEMS syndrome.

Authors:  Jun Feng; Xue-Min Gao; Hao Zhao; Tian-Hua He; Cong-Li Zhang; Kai-Ni Shen; Lu Zhang; Xin-Xin Cao; Ming Qian; Dao-Bin Zhou; Jian Li
Journal:  Blood Adv       Date:  2020-07-28

2.  Serial renal biopsy findings in a case of POEMS syndrome with recurrent acute renal failure.

Authors:  Atsuko Y Higashi; Fumiaki Nogaki; Isoroku Kato; Takahiko Ono; Atsushi Fukatsu
Journal:  Clin Exp Nephrol       Date:  2011-10-08       Impact factor: 2.801

Review 3.  How I treat POEMS syndrome.

Authors:  Angela Dispenzieri
Journal:  Blood       Date:  2012-04-30       Impact factor: 22.113

4.  Bone marrow histopathology in POEMS syndrome: a distinctive combination of plasma cell, lymphoid, and myeloid findings in 87 patients.

Authors:  Linda N Dao; Curtis A Hanson; Angela Dispenzieri; William G Morice; Paul J Kurtin; James D Hoyer
Journal:  Blood       Date:  2011-03-08       Impact factor: 22.113

5.  [Recurrent cerebral ischemias due to cerebral vasculitis within the framework of incomplete POEMS syndrome with Castleman disease].

Authors:  M Rössler; B Kiessling; J M Klotz; H D Langohr
Journal:  Nervenarzt       Date:  2004-08       Impact factor: 1.214

6.  Cerebral infarction in POEMS syndrome: incidence, risk factors, and imaging characteristics.

Authors:  S A Dupont; A Dispenzieri; M L Mauermann; A A Rabinstein; R D Brown
Journal:  Neurology       Date:  2009-10-20       Impact factor: 9.910

7.  Plural light chains in a single plasma cell of a monoclonal gammopathy undetermined significance case: an ultrastructural study.

Authors:  Nagahito Saito; Kohei Konishi; Shuichi Ohta; Takeshi Kondo; Mototsugu Kato; Satoshi Hashino; Hiroshi Takeda; Masahiro Asaka; Hong-Kean Ooi
Journal:  Hum Cell       Date:  2007-02       Impact factor: 4.174

8.  POEMS Syndrome Diagnosed 10 Years after Disabling Peripheral Neuropathy.

Authors:  Viet H Nguyen
Journal:  Case Rep Med       Date:  2011-10-15

9.  Coexistence of Quasi-moyamoya Disease and POEMS Syndrome in a Patient with Intracranial Hemorrhage: A Case Report and Literature Review.

Authors:  Izumi Yamaguchi; Junichiro Satomi; Nobuaki Yamamoto; Shotaro Yoshioka; Yoshiteru Tada; Kenji Yagi; Yasuhisa Kanematsu; Shinji Nagahiro
Journal:  NMC Case Rep J       Date:  2016-12-08

10.  Ischemic stroke in patients with POEMS syndrome: a case report and comprehensive analysis of literature.

Authors:  Fang-Wang Fu; Jie Rao; Yuan-Yuan Zheng; Hui-Lin Wang; Jian-Guang Yang; Guo-Qing Zheng
Journal:  Oncotarget       Date:  2017-08-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.